🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate a gene expression signature (Growth Factor Signatu...
Status
Terminated
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT00860535
Treatments Being Tested
The purpose of this study is to compare the relapse free survival and overa...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2012-08
Trial ID
NCT01782508
Treatments Being Tested
This phase II trial will test the hypothesis that inhibition of c-kit signa...
Status
Terminated
Location
CHU Sainte-Justine
Start Date
2014-06
Trial ID
NCT02177825
Treatments Being Tested
The objectives of the study are: 1. Evaluation of the safety profile of im...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2002-09
Trial ID
NCT00171860
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of 2 starti...
Status
Terminated
Location
Cliniques Universitaire Saint-Luc (Site 058)
Start Date
2015-12-31
Trial ID
NCT02627677
Treatments Being Tested
Multi-center, open-label, non-randomized trial to evaluate long-term safety...
Status
Approved For Marketing
Location
Novartis Investigative Site
Start Date
2008-09
Trial ID
NCT00905593
Treatments Being Tested
This is a randomised, open-label, multicenter, phase III study for adult de...
Status
Active Not Recruiting
Location
Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia
Start Date
2021-09-08
Trial ID
NCT04722848
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Allgemeines Krankenhaus - Universitatskliniken
Start Date
2005-02
Trial ID
NCT00112632
Treatments Being Tested
The objectives of Part 1 of the study were: * To determine the rate of hem...
Status
Completed
Location
Dana Faber Cancer Institute
Start Date
1999-08-09
Trial ID
NCT00171249
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and the safety of das...
Status
Completed
Location
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital
Start Date
2009-03
Trial ID
NCT00866736
Treatments Being Tested